Clinical Care and Rehabilitation for Neuromuscular Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Rehabilitation".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 707
Special Issue Editor
Interests: neurological diseases; clinical neurology; adult neurology; neurorehabilitation; spinal cord injury; brain injury; motor learning; cognitive rehabilitation; neuromuscular disorders
Special Issue Information
Dear Colleagues,
Neuromuscular diseases comprise a heterogeneous group of disorders whose main common feature is progressive or non-progressive muscle weakness.
According to a classification by Sir John Walton, there are around 800 different forms of these diseases, which can be divided into diseases of the muscles, diseases of the peripheral nerves and anterior horn cells, and neuromuscular junction.
While these diseases used to play an outsider role in neurology, advances in modern medicine and neuroscience, especially in molecular genetics, have led to ever better diagnostic and therapeutic options, even for some diseases with a previously poor prognosis, so that the best possible clinical care and rehabilitation of these diseases now play a major role.
For this reason, in this upcoming Special Issue, we want to focus on current scientific aspects of modern clinical care and rehabilitation for all forms of neuromuscular diseases. Clinicians and scientists are cordially invited to submit original research papers or state-of-the-art reviews.
Dr. Hans-Jürgen Gdynia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuromuscular diseases
- myopathy
- neuropathy
- motor neuron disease
- amyotrophic lateral sclerosis
- diseases of neuromuscular junction
- neurorehabilitation
- rehabilitation
- clinical care
- neuroscience
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
